Skip to content

Author

M. Giera

We have 5 of 254 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#gene editing Open access Oct 2026

The Alzheimer’s disease risk gene ABCA7 regulates microglial lysosomal and lipid homeostasis and promotes phagocytosis to maintain neuronal health

Background Loss of function mutations in the lipid transporter ABCA7 have been linked to increased risk for late onset Alzheimer’s disease (AD). Although rare and common variants in ABCA7 associated with AD alter the coding sequence and are predicted to impair protein function, the precise cell-type consequences of ABC...

Sarah E. Heuer, Fasiha Ahsan, Gizem Terzioglu et al. · 0 citations
Open access Aug 2026

Oral Butyrate Reduces Progression of Kidney Damage in an L‐NAME‐Induced Diabetic Kidney Disease Mouse Model

Diabetic kidney disease (DKD) is one of the main causes of kidney failure worldwide. Interestingly, patients affected by DKD are characterised by a low abundance of gut bacteria producing short fatty acids including butyrate, which is suggested to play a role in the decline of renal function. Consequently, we aimed to...

M. Nicese, A. Koudijs, Reshma A. Lalai et al. · 0 citations
Open access Aug 2026

Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation

In vivo FLAP antagonism ameliorates disease severity and spinal cord inflammatory gene expression in the experimental autoimmune encephalomyelitis model, an animal model of MS, in both a prophylactic and therapeutic settings.

J. Konings, Fleur Mingneau, Serhii Chornyi et al. · 0 citations
Open access Aug 2026

From injury to degeneration: delayed lipid-mediated neurotoxicity in a human astrocyte traumatic brain injury in-a-dish model

These findings support a model in which human astrocytes retain a form of ‘injury memory’ through sustained phenotypic and lipid metabolic remodelling, and identify PKC signalling as a tractable target for limiting the long-term consequences of rmTBI.

Luise Schlotterose, M. Struwe, A. Scheidig et al. · 0 citations
Open access Jul 2026

Identification of cellular intermediates unveils unique enzymes for flagellar glycan biosynthesis in Clostridioides difficile.

This study chemically synthesized two hitherto undescribed biosynthetic intermediates that were predicted based on bioinformatic analyses, CDP-threonine and CDP-N-methylthreonine, and showed that they are involved in the Type A PGM biosynthesis, as evidenced by mass spectrometric analyses of extracts of a set of C. dif...

P. Hensbergen, Bob van Puffelen, Nina Musch et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.